| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.6B | $36.2B | $31.0B | $28.2B | $22.8B | $13.1B | $12.7B | $11.8B |
| Cost of Revenue | $31.9B | $30.6B | $25.8B | $23.0B | $18.6B | $10.9B | $10.7B | $10.0B |
| Gross Profit | $5.7B | $5.6B | $5.2B | $5.2B | $4.3B | $2.2B | $2.0B | $1.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.9B | $3.8B | $3.3B | $3.0B | $2.5B | $1.4B | $1.4B | $1.3B |
| Operating Income | $1.6B | $1.6B | $1.7B | $1.9B | $1.7B | $0.7B | $0.5B | $0.4B |
| Net Income | $0.8B | $0.8B | $1.0B | $1.3B | $1.1B | $0.5B | $0.3B | $0.3B |
| EPS (Basic) | $32.38 | $29.71 | $36.36 | $44.38 | $36.81 | $19.74 | $11.70 | $10.91 |
| EPS (Diluted) | $32.32 | $29.65 | $36.29 | $44.17 | $36.54 | $19.53 | $11.60 | $10.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.1B | $23.1B | $19.6B | $15.0B | $11.1B | $7.9B | $6.1B | $5.4B |
| Current Assets | $7.9B | $7.8B | $7.0B | $4.6B | $3.5B | $3.3B | $3.1B | $3.0B |
| Cash & Equivalents | — | — | $0.8B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B |
| Total Liabilities | $18.5B | $16.4B | $13.3B | $9.8B | $6.5B | $5.2B | $4.6B | $4.2B |
| Current Liabilities | $6.7B | $6.6B | $4.9B | $3.2B | $2.4B | $2.5B | $2.6B | $2.5B |
| Stockholders' Equity | $6.6B | $6.7B | $6.2B | $5.2B | $4.6B | $2.7B | $1.5B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $-0.5B | $-0.6B | $1.8B | $0.5B | $0.5B | $0.5B |
| Investing Cash Flow | $-1.0B | $-1.9B | $-1.3B | $-1.3B | $-2.9B | $-1.6B | $-0.4B | $-0.6B |
| Capital Expenditures | $0.4B | $0.4B | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $0.6B | $0.9B | $2.4B | $2.0B | $1.1B | $1.1B | $-0.0B | $0.0B |